Merck & Company Inc
Common Stock · USD · XETRA
Price
$119.6
Cap
—
Earnings
—
30d Trend
+8.2%
33% annualised over 90 days
BRAIN47 SIGNAL
Raw weighted: 57×Macro 0.99 (−1%)=56
RISK
QUALITY
MOMENTUM
TECHNICAL
FUNDAMENTALS
Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%
BRAIN47 HORIZON ANALYSIS
5-10 day swing — momentum continuation
BRAIN47'S ASSESSMENT
I rate Merck & Company Inc at 56/100 — a STRONG reading on the Brain47 Signal. The strongest factor is quality at 67/100. I classify this as a growth position with the strongest thesis on a short-term horizon.
PAST PERFORMANCE
1 MONTH
+20.1%
3 MONTHS
+3.3%
12 MONTHS
+15.0%
Trailing returns — past performance, not a projection.
DETAILED ANALYSIS
5-10 day swing — momentum continuation. Quality (67) and Technical (67) are the primary strengths. I note that momentum is the weakest area at 39/100 — this warrants monitoring. Historical volatility is moderate at 33%. I classify this as a growth position — positive trend direction combined with solid fundamentals points to capital appreciation.
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.